Itaconate shunt hypothesis

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 17:00, March 30, 2023 by Notjusttired (talk | contribs) (Text replacement - ". | authorlink=" to ". | authorlink = ")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Load video
YouTube
Rob Phair presents the Itaconate Shunt Hypothesis for ME/CFS. Jul 12, 2022

The Itaconate Shunt hypothesis for ME/CFS was devised by Dr Robert Phair, PhD, with Professor Ronald Davis at the Open Medicine Foundation. It builds on earlier findings by McGregor et al. (2019).[1][2]

Theory[edit | edit source]

Evidence[edit | edit source]

Treatment[edit | edit source]

Interviews and videos[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ "Dr Rob Phair presents the Itaconate Shunt Hypothesis for ME/CFS". YouTube. July 12, 2022.
  2. ↑ McGregor, Neil R.; Armstrong, Christopher W.; Lewis, Donald P.; Gooley, Paul R. (July 4, 2019). "Post-Exertional Malaise Is Associated with Hypermetabolism, Hypoacetylation and Purine Metabolism Deregulation in ME/CFS Cases". Diagnostics. 9 (3): 70. doi:10.3390/diagnostics9030070. ISSN 2075-4418.

Retrieved from "https://me-pedia.org/w/index.php?title=Itaconate_shunt_hypothesis&oldid=227092"